{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:30:48Z","timestamp":1761183048635,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jiac.2022.04.006","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T02:07:14Z","timestamp":1649642834000},"page":"1029-1032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2738-8642","authenticated-orcid":false,"given":"Takafumi","family":"Yamaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae","family":"Iwasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2022.04.006_bib1","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1164\/rccm.202007-2794OC","article-title":"Outcome of hospitalization for COVID-19 in patients with interstitial lung disease: an international multicenter study","volume":"202","author":"Drake","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2022.04.006_bib2","doi-asserted-by":"crossref","first-page":"2004125","DOI":"10.1183\/13993003.04125-2020","article-title":"Interstitial lung disease increases susceptibility to and severity of COVID-19","author":"Lee","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2022.04.006_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1164\/rccm.202007-2638LE","article-title":"Risk factors for mortality after COVID-19 in patients with preexisting interstitial lung disease","volume":"203","author":"Gallay","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2022.04.006_bib4","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1164\/rccm.202006-2441LE","article-title":"Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control study","volume":"202","author":"Esposito","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2022.04.006_bib5","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jiac.2021.02.028","article-title":"Clinical characteristics of Japanese patients with moderate to severe COVID-19","volume":"27","author":"Otoshi","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2022.04.006_bib6","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 Days in patients with moderate COVID-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2022.04.006_bib7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.resinv.2020.07.004","article-title":"Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019","volume":"58","author":"Awano","year":"2020","journal-title":"Respir Investig"},{"key":"10.1016\/j.jiac.2022.04.006_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40560-020-00466-z","article-title":"D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study","volume":"8","author":"Yao","year":"2020","journal-title":"J Intensive Care"},{"key":"10.1016\/j.jiac.2022.04.006_bib9","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.resinv.2021.04.002","article-title":"Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019","volume":"59","author":"Yamaya","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.jiac.2022.04.006_bib10","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/thoraxjnl-2021-217031","article-title":"Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length","volume":"76","author":"McGroder","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jiac.2022.04.006_bib11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2022.04.006_bib12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with Covid-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2022.04.006_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/jamainternmed.2020.6615","article-title":"Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial","volume":"181","author":"Salvarani","year":"2021","journal-title":"JAMA Intern Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X22001155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:04:25Z","timestamp":1761159865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X22001155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":13,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S1341321X22001155"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2022.04.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2022.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}